Lung cancer prevention: Retinoids and the epidermal growth factor receptor - A phoenix rising?

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 1-3

  Averbuch, Steven D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CARCINOGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GEFITINIB; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID; RETINOID;

CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL RATE; TOBACCO;

ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRETINOIN;

EID: 0036155274     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Emerging therapies in non-small-cell lung cancer
2. st century: Genetics, risk modeling and molecular targets
3. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
4. Evidence for the epidermal growth factor receptor as a target for lung cancer prevention
5. Transcriptional regulation of the EGF receptor promoter HPV 16 and retinoic acid in human ectocervical epithelial cells
6. Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines
7. Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells
8. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines
9. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
10. Cyclin D1 proteolysis: A retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells
11. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung
12. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium
13. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development
14. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor α is frequent in respectable non-small cell lung cancer but does not predict tumor progression
15. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
16. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival
17. The epidermal growth factor receptor and its inhibition in cancer therapy
18. Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
19. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia
20. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis
21. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy
22. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
23. ZD1839 ('Iressa') as an anticancer agent
24. Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies